Chad Bousman

CEO Founder @Sequence2script Inc

Calgary, AB, CA

Pharmacogenomic testing has emerged as an effective strategy for informing drug selection and dosing. This has led to an increase in the use of pharmacogenomic testing in the clinic and has catalyzed the emergence of a burgeoning commercial pharmacogenomic testing industry. As such, laboratories generating pharmacogenomic data require tools for ensuring the prescribing recommendations they provide align with current peer-reviewed prescribing guidelines developed by expert groups and approved product labels. Sequence2Script is a simple to use software solution to assist in the efficient translation of pharmacogenomic data into evidence-based prescribing recommendations.Key Features- 100% evidence-based recommendations across 15 therapeutic areas based on CPIC, DPWG, & FDA guidelines- Tools to create fully customizable pharmacogenetic reports - Efficient and secure report generation via RESTful API - Translate reports into any language- Flexible report options (PDF, JSON, CSV, HTML, HL7), enabling seamless integration with LIMS and EHRs- First-in-class technical supportMore at https://sequence2script.com

UC San Diego School of Medicine

PhD

University of Wisconsin-La Crosse

BS

San Diego State University

MPH